TRAZIMERA 420mg powder for concentrate for solution for infusion PFIZER
trastuzumab Indicated for: HER2-positive cancers
letter T · page 55
trastuzumab Indicated for: HER2-positive cancers
carbocisteine Indicated for: respiratory disorders with viscous secretions
R05CB03 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
treosulfan Indicated for: cancer
L01AB02 Antineoplastic and immunomodulating agents | Alkylating agents | Alkyl sulfonates
treosulfan Indicated for: cancer
L01AB02 Antineoplastic and immunomodulating agents | Alkylating agents | Alkyl sulfonates
nicotinic acid + laropiprant Indicated for: dyslipidemia
quetiapine Indicated for: schizophrenia; bipolar disorder
N05AH04 Nervous system | Antipsychotics | Diazepines, oxazepines, thiazepines and oxepines
quetiapine Indicated for: schizophrenia; bipolar disorder
N05AH04 Nervous system | Antipsychotics | Diazepines, oxazepines, thiazepines and oxepines
quetiapine Indicated for: schizophrenia; bipolar disorder
N05AH04 Nervous system | Antipsychotics | Diazepines, oxazepines, thiazepines and oxepines
quetiapine Indicated for: schizophrenia; bipolar disorder
N05AH04 Nervous system | Antipsychotics | Diazepines, oxazepines, thiazepines and oxepines
fluticasone furoate + umeclidinium + vilanterol Indicated for: asthma; chronic obstructive pulmonary disease
guselkumab Indicated for: autoimmune inflammatory diseases
guselkumab Indicated for: autoimmune inflammatory diseases
guselkumab Indicated for: autoimmune inflammatory diseases
guselkumab Indicated for: autoimmune inflammatory diseases
guselkumab Indicated for: autoimmune inflammatory diseases
guselkumab Indicated for: autoimmune inflammatory diseases
guselkumab Indicated for: autoimmune inflammatory diseases
guselkumab Indicated for: autoimmune inflammatory diseases
pentoxifylline Indicated for: peripheral vascular disease; circulatory disorders
treosulfan Indicated for: cancer
L01AB02 Antineoplastic and immunomodulating agents | Alkylating agents | Alkyl sulfonates